Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Denosumab for treatment of breast cancer bone metastases and beyond
Julie R Nangia,Joseph D Ma,Christine M Nguyen,Margaret AS Mendes,Meghana V Trivedi
Expert Opinion on Biological Therapy.2012;12(4)491
2Denosumab for treatment of breast cancer bone metastases and beyond
Daniele Santini,Chiara Spoto,Vito Longo,Michele Iuliani,Alice Zoccoli,Salvatore Intagliata,Francesco Pantano,Franco Silvestris
Expert Opinion on Biological Therapy.2015;12(4)249
3Denosumab for treatment of breast cancer bone metastases and beyond
Angelina De Sarro,Letteria Minutoli
Expert Opinion on Biological Therapy.2012;12(4)13
4Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma
Gerrard Teoh,Yuming Chen,Kihyun Kim,Alok Srivastava,Vasant R. Pai,Sung-Soo Yoon,Cheolwon Suh,Yeo-Kyeoung Kim
Clinical Lymphoma Myeloma and Leukemia.2012;12(2)118
5Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma
Caterina Musolino,Alessandro Allegra
Clinical Lymphoma Myeloma and Leukemia.2013;12(2)249
6Therapeutic approaches to myeloma bone disease: An evolving story
Vito Longo,Oronzo Brunetti,Stella D’Oronzo,Franco Dammacco,Franco Silvestris
Cancer Treatment Reviews.2012;38(6)787
7Therapeutic approaches to myeloma bone disease: An evolving story
Daniele Santini,Maria Elisabetta Fratto,Matti Aapro
Cancer Treatment Reviews.2012;192(6)171
8Therapeutic approaches to myeloma bone disease: An evolving story
Caroline Wilson,Fiona G. Taylor,Robert E. Coleman
Cancer Treatment Reviews.2013;192(6)531
9Osteoporosis treatment: why ibandronic acid?
Maurizio Rossini,Giovanni Orsolini,Silvano Adami,Vidya Kunnathully,Davide Gatti
Expert Opinion on Pharmacotherapy.2013;14(10)1371
10Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer
Kent Søe,Jean-Marie Delaissé,Erik H. Jakobsen,Charlotte T. Hansen,Torben Plesner
Acta Oncologica.2014;53(4)547
11Zalecenia Polskiej Grupy Szpiczakowej dotyczace rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2013
Anna Dmoszynska,Adam Walter-Croneck,Lidia Usnarska-Zubkiewicz,Beata Stella-Holowiecka,Jan Walewski,Grzegorz Charlinski,Wieslaw Wiktor Jedrzejczak,Elzbieta Wiater,Ewa Lech-Maranda,Joanna Manko,Dominik Dytfeld,Mieczyslaw Komarnicki,Krzysztof Jamroziak,Tadeusz Robak,Artur Jurczyszyn,Aleksander Skotnicki,Krzysztof Giannopoulos
Acta Haematologica Polonica.2013;44(1)3
12Renal complications from bisphosphonate treatment
Raimund Hirschberg
Current Opinion in Supportive and Palliative Care.2012;6(3)342
13Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study
Camila Carvalho de Oliveira,Paulo Goberlânio de Barros Silva,Antonio Ernando Carlos Ferreira,Romélia Pinheiro Gonçalves,Fabrício Bitu de Sousa,Mário Rogério Lima Mota,Ana Paula Negreiros Nunes Alves
Archives of Oral Biology.2017;83(3)317
14Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update
Kenneth Anderson,Nofisat Ismaila,Patrick J. Flynn,Susan Halabi,Sundar Jagannath,Mohammed S. Ogaily,Jim Omel,Noopur Raje,G. David Roodman,Gary C. Yee,Robert A. Kyle
Journal of Clinical Oncology.2018;36(8)812
15The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future
Samantha Pozzi,Noopur Raje
The Oncologist.2011;16(5)651
16Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients
Nelson Leung,Judith Behrens
Advances in Chronic Kidney Disease.2012;19(5)297
17Myeloma light chain cast nephropathy, a review
Insara Jaffer Sathick,Maria Eleni Drosou,Nelson Leung
Journal of Nephrology.2019;32(2)189
18Myeloma light chain cast nephropathy, a review
Caroline Wilson,Fiona Taylor,Robert Coleman
Journal of Nephrology.2018;32(2)439
19Assessment of the efficacy of pulse Ibandronate therapy in non-steroidal anti-inflammatory drug refractory ankylosing spondylitis: An open prospective study
Rathindra Nath Sarkar,Kuntal Bhattacharyya,Sibaji Phaujdar,Dibyendu De
Indian Journal of Rheumatology.2011;6(2)55
20Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models
Julie Rousseau,Virginie Escriou,François Lamoureux,Régis Brion,Julie Chesneau,Séverine Battaglia,Jérome Amiaud,Daniel Scherman,Dominique Heymann,Françoise Rédini,Valérie Trichet
Journal of Bone and Mineral Research.2011;26(10)2452
21Myeloma-related Kidney Disease
Nelson Leung,Samih H. Nasr
Advances in Chronic Kidney Disease.2014;21(1)36

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal